2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
| 热门AI工具： |
论文引言生成
New
AI 写作痕迹检测
Hot
学术改写降重
论文摘要生成
参考文献挖掘工具
审稿意见辅助撰写
|
查看更多AI工具 >> |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Journal of Thoracic Oncology J THORAC ONCOL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 9.2
50人评分
我要评分
声誉 9.9 影响力 8.6 速度 9.4 | |||||||||||||||||||||
| 期刊ISSN | 1556-0864 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||
| E-ISSN | 1556-1380 | |||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||
| 实时影响因子 | 截止2026年9月20日：15.139 | |||||||||||||||||||||
| 2025-2026自引率 | 4.3%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 22.304数据由网友[pixelmaple466]收集提供 | |||||||||||||||||||||
| h-index | 113 | |||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://www.jto.org/ | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/JTO | |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Consensus Statement on ctDNA Minimal Residual Disease Testing in Early Stage NSCLC: A Delphi Study by the Asian Thoracic Oncology Research Group Author: Tan, Aaron C.; Liao, Bin-Chi; Li, Molly; Lee, David; Uehara, Yuji; Thamlikitkul, Lucksamon; Zhang, Jia-Tao; Zheng, Meimei; Lee, Chee Khoon; Pavlakis, Nick; John, Thomas; Soo, Ross A.; Skanderup, Anders; Voon, Pei Jye; Ahn, Beung-Chul; Park, Sehhoon; Hayashi, Hidetoshi; Goto, Yasushi; Horinouchi, Hidehito; Yatabe, Yasushi; Reungwetwattana, Thanyanan; Yang, James Chih-Hsin; Kim, Dong-Wan; Mok, Tony; Tan, Daniel S. W.; Wu, Yi-Long; Ahn, Myung-Ju Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 8, pp. -. DOI: 10.1016/j.jtho.2026.103696 MA04.04 Perioperative Pembrolizumab in Non-Small Cell Cancer (NSCLC): 4-Year Outcomes by Nodal Status in the KEYNOTE-671 Study (vol 20, S67, 2025) Author: Wakelee, Heather A.; Demedts, Ingel; Langleben, Adrian; Yan, Xiaolong; Faehling, Martin; Lo Russo, Giuseppe; Han, Ji-Youn; Levchenko, Evgeny; Ursol, Grygorii; Cronemberger, Eduardo; Wang, Sarah; Zurawski, Bogdan; Voitko, Oleksandr; Jensen, Erin; Keller, Steven; Samkari, Ayman; Jones, David R Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 8, pp. -. DOI: 10.1016/j.jtho.2025.09.124 Durvalumab Consolidation in Limited-Stage SCLC : Outcomes by Prior Concurrent Chemoradiotherapy and Prophylactic Cranial Irradiation in the Phase 3 ADRIATIC Trial Author: Senan, Suresh; Cho, Byoung Chul; Laktionov, Konstantin K.; Zenke, Yoshitaka; Lee, Ki Hyeong; Wang, Qiming; Navarro, Alejandro; Buchmeier, Eva Lotte; Goksu, Sema Sezgin; Badzio, Andrzej; Shi, Anhui; Daniel, Davey B.; Zemanova, Milada; Iyengar, Puneeth; Paz-Ares, Luis; Szadkowski, Leah; Chugh, Priti; Lai, W. Victoria; Spigel, David R Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 8, pp. -. DOI: 10.1016/j.jtho.2026.103703 Targeting MET in EGFR-Mutated NSCLC Author: Saw, Stephanie P. L.; Li, Molly S. C.; Park, Sehhoon; Hatano, Hiroto; Uehara, Yuji; Menis, Jessica; Brandao, Mariana; Hendriks, Lizza E. L.; Remon, Jordi Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 7, pp. -. DOI: 10.1016/j.jtho.2026.103711 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Journal of Thoracic Oncology的语言要求，还能让Journal of Thoracic Oncology编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Journal of Thoracic Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621 | |||||||||||||||||||||
| 出版商 | International Association for the Study of Lung Cancer | |||||||||||||||||||||
| 涉及的研究方向 | 医学-呼吸系统 | |||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||
| 出版年份 | 2006 | |||||||||||||||||||||
| 年文章数 | 108点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 27.60% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 93.52% | |||||||||||||||||||||
| WOS期刊JCR分区 （ 2025-2026年最新版） | 注册或登录后，查看WOS分区等级 | |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
  | ||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1556-0864%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 一般,3-6周 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 较易 | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Journal of Thoracic Oncology顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Consensus Statement on ctDNA Minimal Residual Disease Testing in Early Stage NSCLC: A Delphi Study by the Asian Thoracic Oncology Research Group Author: Tan, Aaron C.; Liao, Bin-Chi; Li, Molly; Lee, David; Uehara, Yuji; Thamlikitkul, Lucksamon; Zhang, Jia-Tao; Zheng, Meimei; Lee, Chee Khoon; Pavlakis, Nick; John, Thomas; Soo, Ross A.; Skanderup, Anders; Voon, Pei Jye; Ahn, Beung-Chul; Park, Sehhoon; Hayashi, Hidetoshi; Goto, Yasushi; Horinouchi, Hidehito; Yatabe, Yasushi; Reungwetwattana, Thanyanan; Yang, James Chih-Hsin; Kim, Dong-Wan; Mok, Tony; Tan, Daniel S. W.; Wu, Yi-Long; Ahn, Myung-Ju Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 8, pp. -. DOI: 10.1016/j.jtho.2026.103696 PubMed DOI |
| 2. | MA04.04 Perioperative Pembrolizumab in Non-Small Cell Cancer (NSCLC): 4-Year Outcomes by Nodal Status in the KEYNOTE-671 Study (vol 20, S67, 2025) Author: Wakelee, Heather A.; Demedts, Ingel; Langleben, Adrian; Yan, Xiaolong; Faehling, Martin; Lo Russo, Giuseppe; Han, Ji-Youn; Levchenko, Evgeny; Ursol, Grygorii; Cronemberger, Eduardo; Wang, Sarah; Zurawski, Bogdan; Voitko, Oleksandr; Jensen, Erin; Keller, Steven; Samkari, Ayman; Jones, David R Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 8, pp. -. DOI: 10.1016/j.jtho.2025.09.124 DOI |
| 3. | Durvalumab Consolidation in Limited-Stage SCLC : Outcomes by Prior Concurrent Chemoradiotherapy and Prophylactic Cranial Irradiation in the Phase 3 ADRIATIC Trial Author: Senan, Suresh; Cho, Byoung Chul; Laktionov, Konstantin K.; Zenke, Yoshitaka; Lee, Ki Hyeong; Wang, Qiming; Navarro, Alejandro; Buchmeier, Eva Lotte; Goksu, Sema Sezgin; Badzio, Andrzej; Shi, Anhui; Daniel, Davey B.; Zemanova, Milada; Iyengar, Puneeth; Paz-Ares, Luis; Szadkowski, Leah; Chugh, Priti; Lai, W. Victoria; Spigel, David R Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 8, pp. -. DOI: 10.1016/j.jtho.2026.103703 PubMed DOI |
| 4. | Targeting MET in EGFR-Mutated NSCLC Author: Saw, Stephanie P. L.; Li, Molly S. C.; Park, Sehhoon; Hatano, Hiroto; Uehara, Yuji; Menis, Jessica; Brandao, Mariana; Hendriks, Lizza E. L.; Remon, Jordi Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 7, pp. -. DOI: 10.1016/j.jtho.2026.103711 PubMed DOI |
| 5. | Outcomes With First-Line Adagrasib With Pembrolizumab in Patients With KRASG12C-Mutated Non-Small Cell Lung Cancer (NSCLC), Including Analysis of Efficacy by Dose Reduction Due to Adverse Events (AEs), From the Phase 2 Portion of the KRYSTAL-7 Study Author: Wu, Sulin; Janne, Pasi A.; Theelen, Willemijn S. M. E.; Garassino, Marina Chiara; Spira, Alexander I.; Laskin, Janessa J.; de Marinis, Filippo; Badin, Firas Benyamine; Boom, Lisenka; De La Rosa, Carlos Aguado; Chmielewska, Izabela; Felip, Enriqueta; Ostoros, Gyula; Jimenez-Kurlander, Lauren; Sachdeva, Archie; Eccles, Laura; Hayati, Sheida; Djidel, Patrick; Lu, Shun Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 7, pp. S6-S7. DOI: |
| 6. | Real World Experience with Combination Chemotherapy-Immunotherapy in Extensive-Stage Small Cell Lung Cancer Author: Schokrpur, Shiruyeh; Singhal, Surbhi; Belamri, Nadra; Ni, Senmiao; Chen, Mengkai; Zhu, Yi; Zou, Xiao; Wu, Evan; Lechpammer, Stan; Riess, Jonathan W.; Gandara, David R Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 7, pp. -. DOI: |
| 7. | Efficacy and Safety of Taletrecfinib in Pafients with ROS1+Non-Small Cell Lung Cancer (NSCLC): Updated Safety Analysis From the Phase 2 TRUST-I and TRUST-II Studies Author: Herrmann, Amanda; Nieva, Jorge J.; Nagasaka, Misako; Liu, Geoffrey; Owen, Scoft; Meng, Xue; Garrido, Pilar; Ran, Feiwu; Wang, Wei; Li, Clara; Zhang, Chris; Bazhenova, Lyudmila Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 7, pp. S12-S12. DOI: |
| 8. | Early Clinical Activity of GT201, a mbIL-15-Engineered Tumor Infiltrating Lymphocyte Therapy in Relapsed EGFR-Mutated Metastatic NSCLC Author: Deshmukh, Shriya; Yu, Jing; Han, Zhengxiang; Li, Xingya; Ma, Liqing; Liu, Yishan; Lu, Lili; Shen, Derun; Wang, Pin; Liu, Yarong; He, Kai Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 7, pp. S37-S38. DOI: |
| 9. | Impact of Germline Mutations and HLA Haplotypes on Clinical Response and Immune-Related Adverse Events (irAEs) in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors Author: Alemnew, Birhan; Liu, Dingning; Zha, Linjun; Patel, Krupa; Liang, Ruqiang; Tong, Caili; Steele, Aaron Paul; Kamiyama, Natalie; Chen, Shuai; Li, Tianhong Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 7, pp. S34-S36. DOI: |
| 10. | First-Line Tislelizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Extensive-Stage SCLC: A Long-Term Survival and Programmed Death-Ligand 1 Subgroup Analysis From the Randomized, Phase 3 RATIONALE-312 Trial Author: Fan, Yun; Zhao, Yanqiu; Huang, Dingzhi; Zhao, Jun; Qin, Tai; He, Wanyu; Chen, Chenqi; Sun, Pu; Naicker, Kirsha; Song, Yong Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 6, pp. -. DOI: 10.1016/j.jtho.2026.103655 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共46条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
